News

Omar Noor leads a dynamic discussion on personalized psoriasis therapy, addressing patient challenges and innovative treatment options.

Clinicians explore innovative strategies for managing atopic dermatitis, emphasizing personalized care and the use of non-steroidal treatments for improved patient outcomes.

Mentors and mentees include specialists in complex medical dermatology, pediatric dermatology, and procedural dermatology to diversify trial opportunities.

April Martinez-Dulay, MSN, APRN, FNP-BC, shares insights on diagnosing and treating types of dermatitis at DERM 2025, emphasizing innovative approaches and patient care strategies.

Vinna Crisostomo, MD, leads vital skin health initiatives in Palawan, addressing access and education challenges for underserved communities on World Skin Health Day.

Clinicians at the SDPA Annual Summer Dermatology Conference explore innovative treatments, diagnostic strategies, and patient-centered care in dermatology.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Walter Liszewski, MD, shares expert strategies for managing body surface area limitations in AD treatment using non-steroidal topicals, and explored key unmet needs in the current therapeutic landscape.

A case report presents a unique case of Bowen's disease affecting the lower extremities in a 75-year-old woman, which was initially misdiagnosed as a fungal infection.

Strong mentorship provides resilience for young clinicians navigating evolving challenges in practice.

James Song, MD, FAAD, reveals insights on abrocitinib's safety in atopic dermatitis, highlighting lower conjunctivitis rates compared to dupilumab at DERM 2025.

Microfocused ultrasound enhances skin quality beyond the face, offering noninvasive solutions for arms and abdomen with high patient satisfaction.

Art Garfunkel raises awareness about psoriasis, sharing his journey and the impact of tildrakizumab treatment in a campaign for support and hope.

In celebration of World Skin Health Day, Jasmin Jamora, MD, and her team at PDS enhance skin health access in remote areas through outreach clinics and education.

The randomized, placebo-controlled trial will evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics in up to 150 healthy volunteers.

Tofacitinib shows promise in treating vitiligo secondary to discoid lupus erythematosus, achieving significant repigmentation and lesion resolution.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

At a Dermatology Times Case-Based Roundtable event, Pearl Grimes, MD, led discussions on diverse vitiligo cases spanning adult, pediatric, and rapidly progressive disease, emphasizing individualized treatment strategies.

World Skin Health Day unites global dermatology leaders to enhance skin health awareness, access, and equity in underserved communities worldwide.

Oversight and endorsement from trusted clinicians were consistent patient requirements for integrating both AI and telemedicine.

At DERM 2025, David Cotter, MD, PhD, shared how GEP testing revolutionizes skin cancer management and enhances patient care at the forefront of dermatology innovation.

Evolus advances facial aesthetics with Evolysse Sculpt, a new hyaluronic acid gel targeting mid-face volume loss, pending FDA approval.

Karen McGuire, PhD, discusses TAMES-02, a clinical trial evaluating TolaSure for Epidermolysis Bullosa Simplex.

This review of the latest dermatologic studies includes a case study of coexisting alopecia and BP treatment, hypochlorous acid for epidermolysis bullosa wounds, DMG-Na and caffeine for hair loss, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

At the Elevate-Derm Summer 2025 meeting, Walter Liszewksi, MD, discussed how new topical therapies, particularly JAK inhibitors, are transforming AD care with rapid itch relief, effectiveness in complex cases, and patient-friendly formulations for sensitive areas.

Explore expert insights from Adam Friedman, MD, FAAD, on emerging topical treatments for atopic dermatitis, featuring real-world cases and practical strategies for improving care and access.

Expanded prescribing rights for pharmacists could ease treatment delays and improve access for AD patients.

Dr. Rossi DERM MD blends dermatologic science with K-beauty aesthetics for effective, evidence-based solutions.